Mahindra & Mahindra Engages Investors at Two Major Conferences in Mumbai on 16 November 2026
Company presents Q2FY27 analyst presentation at Avendus Spark Annual Investor Conference and 29th CITIC CLSA India Forum without sharing unpublished price sensitive information
Mahindra & Mahindra engaged with funds and investors at the Avendus Spark Annual Investor Conference and 29th CITIC CLSA India Forum on 16 November 2026 in Mumbai, presenting the Q2FY27 analyst deck. No unpublished price sensitive information was shared during the events. The presentation is accessible on the company website.
Mahindra & Mahindra Ltd
General / Other
Mahindra & Mahindra Ltd participated in the Avendus Spark Annual Investor Conference and the 29th CITIC CLSA India Forum held in Mumbai on 16 November 2026, presenting its Q2FY27 analyst presentation to funds and institutional investors.
The Company engaged with funds and investors during the events which concluded at 3:00 p.m. IST and 5:00 p.m. IST, respectively, on the same day.
The presentation presented matches the analyst deck submitted to stock exchanges via letter dated 5 November 2026, which is also available on the company’s website.
Mahindra & Mahindra clarified that only publicly available information was discussed during the forums and no unpublished price sensitive information was shared.
The company has complied with SEBI (Listing Obligations and Disclosure Requirements) Regulations by informing stock exchanges about its participation in these investor meetings.
Highlights
- Investor meetings took place on 16 November 2026 in Mumbai.
- Two key events: Avendus Spark Annual Investor Conference and 29th CITIC CLSA India Forum.
- Q2FY27 analyst presentation delivered as per prior submission on 5 November 2026.
- No unpublished price sensitive information was disclosed.
- Presentation is accessible on Mahindra & Mahindra’s official website.
Key Data Snapshot
What happened
- Mahindra & Mahindra participated in two significant investor conferences in Mumbai on 16 November 2026.
- The company interacted with funds, institutional investors, and mutual funds during these events.
- Events concluded at 3:00 p.m. IST (Avendus Spark) and 5:00 p.m. IST (CITIC CLSA Forum) respectively.
Key details
- The company presented its Q2FY27 analyst presentation to attendees.
- This presentation had been previously submitted to stock exchanges on 5 November 2026.
- Only publicly available information was shared; no unpublished price sensitive information was disclosed.
- Notification of these investor meetings was given as per SEBI Listing Regulations requirements.
Regulatory and governance context
- Intimations under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 were complied with.
- Company Secretary Sailesh Kumar Daga signed the communication dated 16 November 2026.
Highlights
- Investor meetings took place on 16 November 2026 in Mumbai.
- Two key events: Avendus Spark Annual Investor Conference and 29th CITIC CLSA India Forum.
- Q2FY27 analyst presentation delivered as per prior submission on 5 November 2026.
- No unpublished price sensitive information was disclosed.
- Presentation is accessible on Mahindra & Mahindra’s official website.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 30 and Schedule III
Source Information
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
State Bank of India Engages with Global Institutional Investors in Singapore Hosted by Bank of America
State Bank of India conducted a meeting with major global institutional investors in Singapore on 17th November 2026, hosted by Bank of America, where only publicly available information was discussed.
Read Full StoryIndia Glycols Posts Rs. 358.18 Crore Revenue and Rs. 39.34 Crore EBITDA in Q2 FY27 Post-Demerger
India Glycols Limited announced its standalone unaudited financial results for the quarter ended September 30, 2026, reporting revenue of Rs. 358.18 crore and EBITDA of Rs. 39.34 crore after demerging its Spirits & Biofuel and Biopharma undertakings into separately listed entities.
Read Full StoryArtemis Medicare Services Limited Opens Special Window for Transfer and Dematerialisation of Physical Securities
Artemis Medicare Services Limited has announced the opening of a Special Window for the transfer and dematerialisation of physical securities through a public notice published on November 17, 2026. This facility allows shareholders to convert their physical share certificates to electronic format within the specified period.
Read Full Story